Paul Tudor Jones Mckesson Corp Call Options Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$473.42 - $539.26 $47,342 - $53,926	100 Added 11.11%	1,000 $536,000
Q4 2023 Feb 14, 2024	BUY	$437.42 - $470.64 $393,678 - $423,576	900 New	900 $416,000
Q4 2022 Feb 14, 2023	BUY	$346.68 - $397.58 $797,364 - $914,434	2,300 Added 95.83%	4,700 $1.77 Million
Q3 2022 Nov 14, 2022	SELL	$321.25 - $373.84 $578,250 - $672,912	-1,800 Reduced 42.86%	2,400 $816,000
Q2 2022 Aug 15, 2022	SELL	$300.57 - $336.42 $2.04 Million - $2.29 Million	-6,800 Reduced 61.82%	4,200 $1.37 Million

Q1 2022 May 16, 2022	BUY	$244.61 - $310.48 $1.3 Million - $1.65 Million	5,300 Added 92.98%	11,000 $3.37 Million
Q4 2021 Feb 14, 2022	BUY	$198.21 - $248.9 $1.13 Million - $1.42 Million	5,700 New	5,700 $1.42 Million

1,674

109M

676K

678K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $83.9B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.